



Freeze prices of life-saving drugs: Pharma IndustryPosted AtIndia InfonlineThe CII on Thursday announced that the
Indian pharmaceutical industry favors freezing prices
of life-saving drugs in core essential pricing, allowing
increases only due to inflation and taxes, to augment
production and supply of such drugs. The pharmaceuticals
industry recommends a short-term price freeze at current
levels with inflationary adjustments on a year-on-year
basis. In the medium term, with industry participation,
a comprehensive and well thought through policy needs
to be evolved. The Mashelkar Committee recommendations1999
must be implemented to spur Indian research. September 15, 2005
|